Optical genome mapping in acute myeloid leukemia: a multicenter evaluation
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007583
Abstract: Key Points • OGM achieves diagnostic outcomes equivalent to, and in 13% of cases better than, standard-of-care technologies in a real-world setting.• OGM may uncover findings that would alter recommended clinical care or render cases… read more here.
Keywords: myeloid leukemia; genome mapping; optical genome; acute myeloid ... See more keywords